Related references
Note: Only part of the references are listed.Noninvasive papillary urothelial carcinoma with pathological features in between low and high grades A case report
Shuang Ma et al.
MEDICINE (2021)
The Clinical Impact of Tumor Grade Heterogeneity in Nonmuscle- invasive Urothelial Carcinoma of the Bladder
Meftun Culpan et al.
Medeniyet medical journal (2021)
CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
Daniel J. Neal et al.
DIAGNOSTIC PATHOLOGY (2020)
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder*
Leonard O. Reis et al.
HUMAN PATHOLOGY (2016)
Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome
Tina Schubert et al.
WORLD JOURNAL OF UROLOGY (2015)
Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence
Zhihong Hu et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Mixed High and Low Grade Bladder Tumors-Are They Clinically High or Low Grade?
Ofer N. Gofrit et al.
JOURNAL OF UROLOGY (2014)
The Efficiency of the EORTC Scoring System for the Prediction of Recurrence and Progression of Non-muscle-invasive Bladder Cancer Treated by Bacillus Calmette-Guerin Immunotherapy
Faouzia Ajili et al.
ULTRASTRUCTURAL PATHOLOGY (2013)
Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non-Muscle-Invasive Urothelial Tumors of the Urinary Bladder
Chin-Chen Pan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system
Hiroshi Miyamoto et al.
PATHOLOGY INTERNATIONAL (2010)
Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis
Nalan Nese et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma
Leona Council et al.
MODERN PATHOLOGY (2009)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder
A Quintero et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Share Paper
